Status in Israel
Presentation and Status in Health Basket
Presentation | Basket | Yarpa | Pharmasoft |
---|---|---|---|
Tablets 30 X 1 mg |
79385 | 9332 |
Related information
Dosage
See prescribing information for full details.
Indications
Treatment of advanced breast cancer in postmenopausal women. Efficacy has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen.Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer.Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.
Contra-Indications
Pre-menopausal women. Pregnancy, lactation. Severe renal impairment.
Drug interactions
Estrogen-containing therapies, concurrent tamoxifen therapy.
Please contact distributing company for full details.
Manufacturer
Teva Pharmaceutical Industries Ltd, Israel
Licence holder